Q1 2024 Embla Medical hf Earnings Call TranscriptApr 23, 2024$4.5Earnings- Q4 2023 Ossur hf Earnings Call TranscriptJan 30, 2024$4.05Earnings
- Q3 2023 Ossur hf Earnings Call TranscriptOct 24, 2023$4.68Earnings
- Q2 2023 Ossur hf Earnings Call TranscriptJul 25, 2023$4.45Earnings
- Q1 2023 Ossur hf Earnings Call TranscriptApr 25, 2023$4.26Earnings
- Ossur hf Corporate Analyst Meeting TranscriptMar 30, 2023
- Q4 2022 Ossur hf Earnings Call TranscriptJan 31, 2023$3.63Earnings
- Q3 2022 Ossur hf Earnings Call TranscriptOct 25, 2022$3.63Earnings
- Q2 2022 Ossur hf Earnings Call TranscriptJul 21, 2022$6.2Earnings
- Preliminary Q2 2022 Ossur hf Earnings Call TranscriptJul 18, 2022$6.2Earnings
- Q1 2022 Ossur hf Earnings Call TranscriptApr 26, 2022$6.2Earnings
- Q4 2021 Ossur hf Earnings Call TranscriptFeb 01, 2022$6.35Earnings
- Q3 2021 Ossur hf Earnings Call TranscriptOct 26, 2021$1.19Earnings
- Q2 2021 Ossur hf Earnings Call TranscriptJul 22, 2021$1.19Earnings
- Q1 2021 Ossur hf Earnings Call TranscriptApr 27, 2021$1.19Earnings
- Q4 2020 Ossur hf Earnings Call TranscriptFeb 02, 2021$1.19Earnings
- Q3 2020 Ossur hf Earnings Call TranscriptOct 27, 2020$7.3Earnings
- Q2 2020 Ossur hf Earnings Call TranscriptJul 23, 2020$7.3Earnings
- Q1 2020 Ossur hf Earnings Call TranscriptApr 30, 2020$7.3Earnings
- Q4 2019 Ossur hf Earnings Call TranscriptFeb 04, 2020$7Earnings
- Full Year 2019 Ossur hf Guidance Call TranscriptJan 14, 2020
- Q3 2019 Ossur hf Earnings Call TranscriptOct 22, 2019$7Earnings
- Q2 2019 Ossur hf Earnings Call TranscriptJul 25, 2019$4.65Earnings
- Q1 2019 Ossur hf Earnings Call TranscriptApr 30, 2019$4.65Earnings
Ossur hf Corporate Analyst Meeting Transcript
Good morning, and welcome, everybody. Welcome to Ãssur Capital Markets Day. My name is Niels Jacobsen. I'm Chairman of Ãssur. I'm CEO of William Demant Invest. And that's the reason for my presence here today.
William Demant Invest have invested in Ãssur since 2004, and the company and the profile and purpose align well with our investment philosophy of owning significant shares in medical device companies that are operating in markets with sustainable favorable growth dynamics. And as you probably know, William Demant Invest is an evergreen investor, meaning that we own our companies on a long-term basis, and we operate our companies not in a way for selling them again. We really think that having this long-term perspective and running the companies in a long-term perspective makes a difference compared to how we see private equity run companies with a view to sale as the main purpose.
Over the last 2 decades, Ãssur have grown consistently through organic growth and acquisitions. The company continues to mature and develop its business model with a goal of improving the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
